Quality indicators of diabetes care in practice.
The objective of this study was to explore the practicability of using process and outcome indicators to routinely assess the quality of diabetes care. Health care data of diabetic patients using antidiabetic drugs older than 40 years old in 2006-2008 were retrieved from an electronic information system of Phramongkutklao Hospital, Thailand. The process and outcome indicators were taken from the standard of medical care in diabetes of the American Diabetes Association, 2006 - 2008 and other studies. A list of the practical indicators was selected according to the availability and completeness of the electronic data in the information system, consisting of glycemic control, lipid control, and antiplatelet therapy. For process indicators, the percentages of patients with a yearly measured HbAlc, LDL-cholesterol, triglyceride, HDL-cholesterol, and antiplatelet therapy were 56.5-67.2, 87.8-90.2, 76.6-81.4, 71.8-75.5, and 69.7-75.9%, respectively. For outcome indicators, the percentages of patients with most recent blood levels of HbAlc, LDL-cholesterol, triglyceride, and HDL-cholesterol at target levels were 25.1-32.5, 27.7-33.9, 50.1-54.7, and 53.1-62.5%, respectively. The practicability of these quality indicators in determining the quality of diabetes care will depend on the quality of the hospital electronic databases. Among these applicable indicators at this particular setting, the glycemic and lipid control, and antiplatelet therapy seemed to be sufficiently provided according to the standard diabetes care recommendation. However, the poor outcomes as measured by lipid profiles and HbAlc suggested that other intervention may also be necessitated to better these outcomes.
Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand. inthira_k@hotmail.com
Inthira
I
Kanchanaphibool
Sanita
S
Hirunrassami
Pensri
P
Tongpugdee
D000328:Adult; D000369:Aged, 80 and over; D001794:Blood Pressure; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003920:Diabetes Mellitus / Q000628:therapy*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019984:Quality Indicators, Health Care; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D006442:Glycated Hemoglobin; D010975:Platelet Aggregation Inhibitors; D014280:Triglycerides